The Buffalo Bills face a challenging start to the 2025 NFL season as two newly signed defensive linemen, Larry Ogunjobi and Michael Hoecht, have been suspended for violating the league's performance-enhancing drug policy. The suspension will keep them from participating in the first six games of the season, a significant setback for the Bills. General manager Brandon Beane expressed surprise at Ogunjobi's suspension, highlighting that both players accepted responsibility and are unsure of the substances involved. They can still participate in preseason activities but must adhere to strict training protocols to return after their suspension. This incident raises questions about the league’s stance on performance-enhancing drugs and the impact on player integrity and team morale.